Search

Your search keyword '"Zattoni F"' showing total 1,139 results

Search Constraints

Start Over You searched for: Author "Zattoni F" Remove constraint Author: "Zattoni F"
1,139 results on '"Zattoni F"'

Search Results

2. Which is the optimal multimodal management of pN1 patients with PSA persistence after radical prostatectomy and extended nodal dissection? Results of a large, multi-institutional database

3. The impact of multiple lesions in prostate MRI – insights from the YAU prostate cancer group

4. The highest grade group does not drive the risk of advanced stage when systematic and multiparametric Magnetic Resonance Imaging (MRI)-targeted biopsies are discordant: Results from a large multi-institutional series

5. Optimizing detection and prediction of prostate cancer after positive MRI and negative biopsies

7. A prospective randomized multicenter study on the impact of 18F-Choline PET/CT versus conventional imaging for staging intermediate - to high-risk prostate cancer

9. External validation of the available nomograms for the identification of candidates for a staging extended pelvic lymph node dissection at the time of radical prostatectomy in prostate cancer patients preoperatively staged with PSMA PET

10. Do incidental prostate cancer patients managed with active surveillance exhibit different disease features and outcomes compared to their biopsy-diagnosed counterparts? Results of a multi-institutional study

11. Oncological outcomes of pN1 prostate cancer patients treated with radical prostatectomy: Does molecular imaging have a prognostic impact? Results of a large, multi-institutional series

12. Can we rely on available models predicting pathological outcomes in prostate cancer patients staged with 68-Ga PSMA-PET/CT? External validation of the existing nomograms for extracapsular extension and seminal vesicle invasion at radical prostatectomy and development of a novel tool including intraprostatic SUVmax

13. Adjuvant or early salvage radiotherapy in node positive prostate cancer patients: Development of a novel risk score to identify the optimal candidate for early intensification approaches based on a large, multi-institutional series

14. Einfluss von RAS-Inhibitoren auf die Aggressivität des Prostatakarzinoms - eine retrospektive multizentrische Analyse

19. Surgeons’ perspectives on artificial intelligence to support clinical decision-making in trauma and emergency contexts: results from an international survey

20. Time for a paradigm shift in shared decision-making in trauma and emergency surgery? Results from an international survey

21. Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on PSMA-PET: Results of a Multicenter, European Study

22. Robotic YV plasty for recurrent bladder neck contracture

24. Robot-assisted repair of plurirecurrent vesico-vaginal fistula

26. Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsy on the Risk of Upgrading in Final Pathology in Prostate Cancer Patients Undergoing Radical Prostatectomy? An European Association of Urology-Young Academic Urologists Prostate Cancer Working Group Multi- institutional Study

27. A systematic review of the efficacy and toxicity of brachytherapy boost combined with external beam radiotherapy for nonmetastatic prostate cancer

28. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.

30. Improving prediction of local stage by PSMA-PET: Development of a novel integrated tool for extracapsular extension and seminal vesicle invasion combining clinical and imaging features in localized prostate cancer

31. Signification pronostique de la tumeur résiduelle à la résection de second look dans le tumeur de vessie non infiltrant le muscle de haut risque.

32. Diminution du risque de récidive chez les patients présentant une TVNIM T1 : ce qui compte vraiment. Une étude européenne multicentrique rétrospective.

33. Unilateral pelvic lymph node dissection in prostate cancer patients diagnosed in the era of MRI-targeted biopsy: A study that challenges the dogma

35. Prädiktoren für eine ungünstige Histologie bei Patienten mit inzidentellem Prostatakarzinom

36. Assessment of health-related quality of life in patients with advanced prostate cancer current state and future perspectives

37. Biomarkers to personalize treatment with 177Lu-PSMA-617 in men with metastatic castration-resistant prostate cancer - a state of the art review

39. Challenging the dogma : Should unilateral pelvic lymph node dissection be envisioned in the multiparametric prostate MRI era?

40. Assessment of Health-Related Quality of Life in Patients with Advanced Prostate Cancer-Current State and Future Perspectives

43. Risk of adverse outcomes after prostatectomy in patients diagnosed with IUSP <= 2 prostate cancer on MRI/TRUS fusion biopsy

45. Challenging the dogma: Should unilateral pelvic lymph node dissection be envisioned in the multiparametric prostate MRI era?

46. Abiraterone versus Docetaxel in der Erstlinientherapie des metastasierten hormonsensitiven Prostatakarzinoms – ein multizentrischer Vergleich

47. Docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer: a real-life analysis

Catalog

Books, media, physical & digital resources